Bezstronne i praktyczne aktualizacje z psychofarmakologii

Quick Takes

Najnowsze badania, które mają znaczenie w praktyce klinicznej. Punkty CME dostępne.

Brain Guides

Przewodniki syntetyzujące piśmiennictwo, ułatwiające bezpieczne przepisywanie leków. Punkty CME dostępne.

Video Lectures

Wybór praktycznych sekcji z naszych Video Lectures. Punkty CME dla członków Bronze i Silver.

NAJNOWSZE PUBLIKACJE

Client Repro Course pl

Brak punktów
mohamed.ahamed
Zobacz więcej informacji

Aktualizacja z sierpnia 2026: centanafadyna, oweporekston oraz nowe wytyczne dotyczące OCD, litu i bezsenności

0,75 punktów CME
This guide covers the two first-in-class approvals of mid-2026, centanafadine for ADHD and oveporexton for narcolepsy type 1, alongside new guidance on OCD dosing thresholds, the serum lithium levels that drive renal risk, and the AASM’s ranking of CBT-I against combination treatment for chronic insomnia.
Sebastián Malleza, M.D.
Psychopharmacology Institute
Zobacz więcej informacji

Quick Take Vol. 90

0,75 punktów CME
Czy prenatalna ekspozycja na leki przeciwdepresyjne powoduje autyzm lub ADHD u potomstwa? Jak oceniać ryzyko sercowe przy łączeniu leku przeciwpsychotycznego z SSRI? Kiedy należy ponownie włączyć klozapinę pacjentowi po epizodzie neutropenii? Czy schizofrenia powinna zostać przemianowana? Czy dodanie ashwagandhy do melatoniny poprawia sen bardziej niż każdy z tych preparatów stosowany osobno?
Kadra: Amanda Koire, M.D., Ph.D., Scott R. Beach, M.D., Oliver Freudenreich, M.D., F.A.C.L.P., Derick E. Vergne, M.D.
47,15 minut w 5 sekcjach audio

Farmakoterapia przewlekłej bezsenności: praktyczny przewodnik

1,0 punktów CME
Praktyczny przewodnik po farmakologicznym leczeniu przewlekłej bezsenności. Dr Kolla omawia podwójnych antagonistów receptorów oreksyny, leki z grupy Z, benzodiazepiny, melatoninę i ramelteon, leki przeciwdepresyjne o działaniu sedatywnym oraz leki przeciwpsychotyczne, a także postępowanie w ciąży, u pacjentów w podeszłym wieku oraz przy długotrwałym stosowaniu.
Bhanu Prakash Kolla, M.D.
Mayo Clinic
55,07 minut w 11 sekcjach

Hiponatremia indukowana lekami przeciwdepresyjnymi: mechanizmy, ryzyko, diagnostyka i leczenie

0,50 punktów CME
This guide gives prescribers an evidence-based approach to antidepressant-associated hyponatremia: how the syndrome of inappropriate antidiuresis (SIAD) develops, which patients to monitor and when, how to recognize symptoms that may mimic depression, and how to manage and apply switching strategies afterward.
Sebastián Malleza, M.D.
Psychopharmacology Institute
Zobacz więcej informacji

Quick Take Vol. 89

0,50 punktów CME
Czy leki przeciwpsychotyczne mogą pomóc w zapobieganiu nawrotom katatonii? Który wspomagający lek przeciwpsychotyczny wykazuje najlepszą skuteczność w leczeniu dużej depresji? Co zaktualizowane rankingi skuteczności leków przeciwpsychotycznych oznaczają dla praktyki klinicznej w schizofrenii? Czy agoniści receptora GLP-1 są bezpieczni dla pacjentów ze współistniejącymi zaburzeniami lękowymi? Czy wareniklina pomaga pacjentom rzucić wapowanie?
Kadra: Scott R. Beach, M.D., James Phelps, M.D., Oliver Freudenreich, M.D., F.A.C.L.P., Derick E. Vergne, M.D., David A. Gorelick, M.D., Ph.D., D.L.F.A.P.A., F.A.S.A.M.
35,33 minut w 5 sekcjach audio

Zapraszamy do naszej obszernej biblioteki filmów, streszczeń badań i wywiadów z ekspertami.

CME Information

Physicians – CME Accreditation Statement

The activities below have been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Academy LLC and the Psychopharmacology Institute. Medical Academy LLC is accredited by the ACCME to provide continuing medical education for physicians.

Medical Academy, LLC designates each enduring material for the number of AMA PRA Category 1 Credits™ listed below. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Download Accreditation Information (PDF)

Nursing professionals – CME Accreditation Statement

The activities below have been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Academy LLC and the Psychopharmacology Institute. Medical Academy LLC is accredited by the ACCME to provide continuing medical education for physicians.

Medical Academy, LLC designates each enduring material for the number of AMA PRA Category 1 Credits™ listed below. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The ANCC accepts AMA PRA Category 1 Credit(s)™ as Contact Hours, under this calculation: 1 CME = 1 Contact Hour. 

All of our content is psychopharmacology, so the pharmacology hours shown on your certificate match the credits awarded for that activity. Your certificate states them on their own line, separately from the credit designation statement.

This applies to APRN pharmacology renewal as well. Boards of nursing define pharmacology CE in their own way, so please confirm with your board that this is the documentation they expect.

Download Accreditation Information (PDF)

Physician assistants – CME Accreditation Statement

The activities below have been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Academy LLC and the Psychopharmacology Institute. Medical Academy LLC is accredited by the ACCME to provide continuing medical education for physicians.

Medical Academy, LLC designates each enduring material for the number of AMA PRA Category 1 Credits™ listed below. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The NCCPA accepts AMA PRA Category 1 Credit™ from providers accredited by the ACCME toward PA certification maintenance. Requirements are set by the NCCPA, so please confirm with them what your current cycle requires.

Download Accreditation Information (PDF)

Physicians outside the United States – CME Accreditation Statement

AMA PRA Category 1 Credit™ may be awarded to any physician, whether or not they are licensed in the United States. The requirements are the same.

The American Medical Association has an agreement of mutual recognition of Continuing Medical Education (CME) credits with the European Union of Medical Specialists (UEMS), the accreditation body for European countries. Physicians interested in converting AMA PRA Category 1 Credit™ to UEMS-European Accreditation Council for Continuing Medical Education CME credits (ECMEC®s) should contact the UEMS at mutualrecognition@uems.eu.

Whether these credits count toward your own national continuing education requirement is decided by your national medical chamber or society, and the rules differ from country to country. We recommend confirming with them before relying on the credits for a licensing or recertification requirement.

Self Assessment for MOC – Accreditation Statement
  • Psychopharmacology Institute Self-Assessment Program 2026

Dates: April 1, 2026 – April 1, 2029

The American Board of Psychiatry and Neurology has reviewed the Psychopharmacology Institute Self-Assessment Program 2026 and has approved this activity as part of a comprehensive Self-Assessment activity, which is mandated by the ABMS as a necessary component of Continuing Certification.

  • Psychopharmacology Institute Self-Assessment Program 2025

Dates: April 1, 2025 – April 1, 2028

The American Board of Psychiatry and Neurology has reviewed the Psychopharmacology Institute Self-Assessment Program 2025 and has approved this activity as part of a comprehensive Self-Assessment activity, which is mandated by the ABMS as a necessary component of Continuing Certification.

  • Psychopharmacology Institute Self-Assessment Program 2024

Dates: April 1, 2024 – April 1, 2027

The American Board of Psychiatry and Neurology has reviewed the Psychopharmacology Institute Self-Assessment Program 2024 and has approved this activity as part of a comprehensive Self-Assessment activity, which is mandated by the ABMS as a necessary component of Continuing Certification.

Czują się Państwo zagubieni na początku rezydentury z psychiatrii?

BEZPŁATNY dostęp do WSZYSTKICH naszych produktów przez 3 miesiące!